Strides Pharma stocks: Buy Strides Pharma Science, target price Rs 630: Prabhudas Lilladher
Promoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.
Source: indiatimes.com
Stay updated with breaking news from Arcolab Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Promoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.
Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 4766.18 Crore) operating in Pharmaceuticals sector.